Company / Operating Cash Flow per Share
NOVAVAX INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.52
FY2025
5-year range
-$8.30 / $4.55
FY2021-FY2025
Trend
-143.8%
vs FY2024
Sector context
#134 of 212
Health Care
What the data says
At $-1.52, NOVAVAX INC's operating cash flow per share ranks #134 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-8.30 in FY2023 to $4.55 in FY2021.
Based on SEC 10-K filings.
-1.52 in FY2025.
Improved from $-8.30 to $-1.52 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#134 of 212 in Health CareTop 63% of 212This company -$1.52 Sector average $5.28
▼
-128.9% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 143.8% year-over-year.
- Ranks #134 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.52 | -143.8% |
| FY2024 | -$0.63 | +92.5% |
| FY2023 | -$8.30 | -1379.4% |
| FY2022 | -$0.56 | -112.3% |
| FY2021 | $4.55 | +446.1% |
| FY2020 | -$1.31 | +82.5% |
| FY2019 | -$7.52 | -838.8% |
| FY2018 | -$0.80 | -72.2% |
| FY2017 | -$0.46 | -87.3% |
| FY2016 | -$0.25 | -30.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026